What type of study is this?

Impact of prophylactic biliary stenting on stone recurrence and post-endoscopic retrograde cholangiopancreatography complications in patients awaiting cholecystectomy: a randomized controlled trial

View Full Paper

Ask AI

Bookmark

Authors

Randomized controlled trial examines biliary stenting impact on CBD stone recurrence and complications, suggesting reconsideration of routine use.

Prophylactic biliary stenting did not reduce recurrence of CBD stones, with 19.0% recurrence in the stent group compared to 7.9% without.
The overall complication rate was higher in the stent group at 11.9%, with pancreatitis and cholecystitis reported but none in the non-stent cohort.
Patients underwent a prospective randomized controlled trial across a tertiary center, monitored for three months following ERCP treatment.
These findings suggest that routine stent use in patients awaiting cholecystectomy may need reevaluation due to increased complication rates.

Mishra et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized controlled trial examines biliary stenting impact on CBD stone recurrence and complications, suggesting reconsideration of routine use.